Stepwise Application of Urine Markers to Detect Tumor Recurrence in Patients Undergoing Surveillance for Non-Muscle-Invasive Bladder Cancer

Table 1

Patients’ characteristics.

Total number of patients	483
Median age (range)	70 (31–94)
Gender (male/female)	406/77
Tumor at time of urine marker sampling (%)	128 (26.5)
pTa (%)	86 (67.2)
pT1 (%)	15 (11.7)
≥pT2 (%)	14 (10.9)
Pure Cis (%)	13 (10.1)
Concomitant Cis (%)	8 (6.3)
G1 (%)	53 (42.4)
G2 (%)	38 (29.7)
G3 (%)	25 (19.5)
Interval between last tumor and urine marker sampling (median, range; months)	6 (2–94)